NasdaqGS · Stocky rates: Hold

Afya Limited (AFYA)

$13.63 ▼ -2.22% as of 5 Aug, 22:58
69
/ 100
Hold

What Stocky thinks

Hold. AFYA's 76 Growth Compounder Score reflects solid execution in Brazilian medical education, but a maxed-out Vulnerability Index (financial buffer only) signals concentration risk and thin margins that limit upside. Leadership Alignment at 54/100 suggests misalignment between insiders and shareholders. Cheap valuation (7.6x forward P/E) prices in headwinds; wait for structural improvement before adding.

Compounder Score
76/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
54/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
67/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Afya Limited:

69
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 69/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

54
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Afya Limited (AFYA) — frequently asked

Is Afya Limited (AFYA) a good investment right now?

Stocky rates Afya Limited (AFYA) at 69/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. AFYA's 76 Growth Compounder Score reflects solid execution in Brazilian medical education, but a maxed-out Vulnerability Index (financial buffer only) signals concentration risk and thin margins that limit upside. Leadership Align

What is AFYA's Stocky Verdict?

AFYA's current Stocky Verdict is 69/100, placing it in the "Hold" band. This composite combines a 76/100 Compounder score, 54/100 Leadership, Moat rating, and analyst signal.

Does Afya Limited have a competitive moat?

Stocky hasn't finalised a Moat Score for Afya Limited yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is Afya Limited's leadership aligned with shareholders?

Afya Limited scores 54/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to AFYA?

Afya Limited's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Afya Limited.

This is just the surface. See the whole picture on Afya Limited.

Sign up free and unlock the full analysis on AFYA — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering AFYA — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for AFYA.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how AFYA changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to AFYA?" · "Is AFYA overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
69
/ 100 · Hold

Or jump straight to the interactive dashboard for AFYA in the app.